| Literature DB >> 26629081 |
Bin Hong1, Lin-Lin Yao1, Xing-Yue Hu1.
Abstract
Botulinum toxin type A (BoNT/A) can specifically cleave synaptosomal associated protein of 25 kDa (SNAP-25) into cleaved SNAP-25 (cl.SNAP-25), thus blocking the synaptic transmission in motor end plate and resulting in paralysis. It has been widely applied in clinical for treatment of various conditions characterized by muscle hyperactivity, such as dystonia and spasticity. BoNT/A is used locally, with little diffusion. Its paralyzing role is considered to be restricted to the nerve muscle junction, or close to the injection site. Recently, more and more studies, however, have suggested that BoNT/A also has central effects. In addition, some investigators have demonstrated that BoNT/A enters into central nervous system via retrograde transport after local intramuscular administration. The retrograde axonal transport of Chinese BoNT/A (CBoNT/A) was studied in this paper, which was rare in report. And the results showed that cl.SNAP-25 appeared not only at the injection site but also in contralateral muscle. Retrograde transport, however, was non-existent or too little to be detected in our study.Entities:
Keywords: Botulinum toxin type A; cleaved SNAP-25; gastrocnemius; remote effect; retrograde transport
Year: 2015 PMID: 26629081 PMCID: PMC4658970
Source DB: PubMed Journal: Int J Clin Exp Med ISSN: 1940-5901